Summary
ULURU Inc (ULURU) is a pharmaceutical company that develops and commercializes wound care and muco-adhesive film products. The company offers products such as Altrazeal, Apthasol, OraDisc W, and others. Its Altrazeal is a transforming powder dressing with Nanoflex technology for the management of exuding wounds. ULURU’s Apthasol is used for treating aphthous ulcers in people with normal immune systems. The company’s OraDisc is a polymer solid dosage form used to deliver amlexanox to the mucosal tissue. It also research and develops Nanoflex technology which is designed for optimizing the wound bed environment and accelerate healing. ULURU is headquartered in Addison, Texas, the US.
ULURU Inc (ULUR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
ULURU Inc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
ULURU Inc, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
ULURU Inc, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
ULURU Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
ULURU Inc, Medical Devices Deals, 2010 to YTD 2016 9
ULURU Inc, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
ULURU Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
ULURU Partners with Saraya 11
Licensing Agreements 12
Uluru Expands Licensing Agreement with Altrazeal 12
Uluru Expands Licensing Agreement With Altrazeal 13
Uluru Expands Licensing Agreement With Altrazeal 14
ULURU Enters Into Licensing Agreement With Melmed Holdings For Altrazeal 15
ULURU Expands Licensing Agreement With Melmed For Altrazeal To Middle East And North Africa 16
ULURU Expands Licensing Agreement With Melmed For Altrazeal 17
Uluru Enters Into Licensing Agreement With Jiangxi Aiqilin Pharma 18
Equity Offering 19
Uluru to Raise USD1.8 Million in Private Placement of Shares and Warrants 19
Uluru to Raise USD1.6 Million in Private Placement of Shares 20
Uluru Completes First Tranche Of Private Placement Of Shares For US$0.09 Million 21
Uluru Completes First Tranche Of Private Placement Of Shares For US$0.4 Million 22
Uluru Increases Size Of Private Placement Of Shares For US$2.4 Million 23
ULURU Files Registration Statement For Private Placement Of Shares For US$1 Million 25
Uluru Completes Private Placement Of Preferred Shares For US$1 Million 27
ULURU Completes Registered Direct Offering Of Its Common Stock For US$0.5 Million 29
ULURU Completes Registered Direct Offering Of Common Stock For US$1 Million 31
Debt Offering 33
Uluru Completes First Tranche Of Private Placement Of 8% Secured Convertible Notes For US$0.7 Million 33
Asset Transactions 34
Crawford Healthcare Acquires Zindaclin From ULURU And Strakan 34
ULURU Inc - Key Competitors 35
Key Employees 36
Locations And Subsidiaries 37
Head Office 37
Appendix 38
Methodology 38
About GlobalData 38
Contact Us 38
Disclaimer 38
List of Tables
ULURU Inc, Pharmaceuticals & Healthcare, Key Facts, 2015 1
ULURU Inc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
ULURU Inc, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
ULURU Inc, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
ULURU Inc, Deals By Therapy Area, 2010 to YTD 2016 8
ULURU Inc, Medical Devices Deals, 2010 to YTD 2016 9
ULURU Inc, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
ULURU Partners with Saraya 11
Uluru Expands Licensing Agreement with Altrazeal 12
Uluru Expands Licensing Agreement With Altrazeal 13
Uluru Expands Licensing Agreement With Altrazeal 14
ULURU Enters Into Licensing Agreement With Melmed Holdings For Altrazeal 15
ULURU Expands Licensing Agreement With Melmed For Altrazeal To Middle East And North Africa 16
ULURU Expands Licensing Agreement With Melmed For Altrazeal 17
Uluru Enters Into Licensing Agreement With Jiangxi Aiqilin Pharma 18
Uluru to Raise USD1.8 Million in Private Placement of Shares and Warrants 19
Uluru to Raise USD1.6 Million in Private Placement of Shares 20
Uluru Completes First Tranche Of Private Placement Of Shares For US$0.09 Million 21
Uluru Completes First Tranche Of Private Placement Of Shares For US$0.4 Million 22
Uluru Increases Size Of Private Placement Of Shares For US$2.4 Million 23
ULURU Files Registration Statement For Private Placement Of Shares For US$1 Million 25
Uluru Completes Private Placement Of Preferred Shares For US$1 Million 27
ULURU Completes Registered Direct Offering Of Its Common Stock For US$0.5 Million 29
ULURU Completes Registered Direct Offering Of Common Stock For US$1 Million 31
Uluru Completes First Tranche Of Private Placement Of 8% Secured Convertible Notes For US$0.7 Million 33
Crawford Healthcare Acquires Zindaclin From ULURU And Strakan 34
ULURU Inc, Key Competitors 35
ULURU Inc, Key Employees 36
List of Figures
ULURU Inc, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
ULURU Inc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
ULURU Inc, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
ULURU Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
ULURU Inc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
ULURU Inc, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
ULURU Inc, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
ULURU Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
ULURU Inc, Medical Devices Deals, 2010 to YTD 2016 9
